Purified CD4+ T cells were activated with the indicated stimuli
. | Soluble FasL . | Membrane-bound FasL . | ||
---|---|---|---|---|
CD3 . | CD3 + Lptn . | CD3 . | CD3 + Lptn . | |
Day 1 | 3.1 (1.2) | 1.4 (0.6) | 1.7 (0.9) | 1.8 (1.1) |
Day 2 | 5.6 (0.7) | 1.7 (0.6) | 1.4 (0.6) | 4.5 (1.1) |
Day 3 | 11.7 (2.5) | 2.4 (2.0) | 1.2 (0.1) | 1.4 (0.6) |
. | Soluble FasL . | Membrane-bound FasL . | ||
---|---|---|---|---|
CD3 . | CD3 + Lptn . | CD3 . | CD3 + Lptn . | |
Day 1 | 3.1 (1.2) | 1.4 (0.6) | 1.7 (0.9) | 1.8 (1.1) |
Day 2 | 5.6 (0.7) | 1.7 (0.6) | 1.4 (0.6) | 4.5 (1.1) |
Day 3 | 11.7 (2.5) | 2.4 (2.0) | 1.2 (0.1) | 1.4 (0.6) |
Cellular extracts and supernatants were prepared at the indicated times and analyzed for expression of the soluble and membrane-bound forms of FasL in the same ELISAs, according to the manufacturer's protocol. Mean concentrations in ng/mL (bold characters) with SD between parentheses are representative of at least 2 independent experiments.
Lptn indicates lymphotactin; ELISA, enzyme-linked immunosorbent assay.